Micronization of cilostazol using supercritical antisolvent (SAS) process: Effect of process parameters

Min Soo Kim, Sibeum Lee, Jeong Sook Park, Jong Soo Woo, Sung Joo Hwang

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

The aim of this study was to improve dissolution rate of poorly water-soluble drug, cilostazol, using supercritical antisolvent (SAS) process. The effect of process variables, such as pressure, temperature, drug concentration, type of solvents, feed rate ratio of CO2/drug solution, on drug particle formation during SAS process was investigated. Particles with mean particle size ranging between 0.90 and 4.52 μm were obtained by varying process parameters such as precipitation vessel pressure and temperature, drug solution concentration, solvent type, feed rate ratio of CO2/drug solution. In particular, mean particle size and distribution were markedly influenced by drug solution concentration during SAS process. Moreover, the drug did not change its crystal form and the operating parameters might control the 'crystal texture' due to the change in crystallinity and preferred orientation during SAS process, as confirmed by differential scanning calorimetry and powder X-ray diffraction study. In addition, the dissolution rate of drug precipitated using SAS process was highly increased in comparison with unprocessed drug. Therefore, it is concluded that the dissolution rate of drug is significantly increased by micronization of cilostazol, leading to the reduction in particle size and increased specific surface area after SAS process.

Original languageEnglish
Pages (from-to)64-70
Number of pages7
JournalPowder Technology
Volume177
Issue number2
DOIs
Publication statusPublished - 2007 Aug 15

Fingerprint

Dissolution
Particle size
Pharmaceutical Preparations
Crystals
Pressure vessels
Specific surface area
X ray powder diffraction
Differential scanning calorimetry
Textures
Temperature
cilostazol
Water

All Science Journal Classification (ASJC) codes

  • Chemical Engineering(all)

Cite this

Kim, Min Soo ; Lee, Sibeum ; Park, Jeong Sook ; Woo, Jong Soo ; Hwang, Sung Joo. / Micronization of cilostazol using supercritical antisolvent (SAS) process : Effect of process parameters. In: Powder Technology. 2007 ; Vol. 177, No. 2. pp. 64-70.
@article{57359dc9e891420eaf2d38116d75bf37,
title = "Micronization of cilostazol using supercritical antisolvent (SAS) process: Effect of process parameters",
abstract = "The aim of this study was to improve dissolution rate of poorly water-soluble drug, cilostazol, using supercritical antisolvent (SAS) process. The effect of process variables, such as pressure, temperature, drug concentration, type of solvents, feed rate ratio of CO2/drug solution, on drug particle formation during SAS process was investigated. Particles with mean particle size ranging between 0.90 and 4.52 μm were obtained by varying process parameters such as precipitation vessel pressure and temperature, drug solution concentration, solvent type, feed rate ratio of CO2/drug solution. In particular, mean particle size and distribution were markedly influenced by drug solution concentration during SAS process. Moreover, the drug did not change its crystal form and the operating parameters might control the 'crystal texture' due to the change in crystallinity and preferred orientation during SAS process, as confirmed by differential scanning calorimetry and powder X-ray diffraction study. In addition, the dissolution rate of drug precipitated using SAS process was highly increased in comparison with unprocessed drug. Therefore, it is concluded that the dissolution rate of drug is significantly increased by micronization of cilostazol, leading to the reduction in particle size and increased specific surface area after SAS process.",
author = "Kim, {Min Soo} and Sibeum Lee and Park, {Jeong Sook} and Woo, {Jong Soo} and Hwang, {Sung Joo}",
year = "2007",
month = "8",
day = "15",
doi = "10.1016/j.powtec.2007.02.029",
language = "English",
volume = "177",
pages = "64--70",
journal = "Powder Technology",
issn = "0032-5910",
publisher = "Elsevier",
number = "2",

}

Micronization of cilostazol using supercritical antisolvent (SAS) process : Effect of process parameters. / Kim, Min Soo; Lee, Sibeum; Park, Jeong Sook; Woo, Jong Soo; Hwang, Sung Joo.

In: Powder Technology, Vol. 177, No. 2, 15.08.2007, p. 64-70.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Micronization of cilostazol using supercritical antisolvent (SAS) process

T2 - Effect of process parameters

AU - Kim, Min Soo

AU - Lee, Sibeum

AU - Park, Jeong Sook

AU - Woo, Jong Soo

AU - Hwang, Sung Joo

PY - 2007/8/15

Y1 - 2007/8/15

N2 - The aim of this study was to improve dissolution rate of poorly water-soluble drug, cilostazol, using supercritical antisolvent (SAS) process. The effect of process variables, such as pressure, temperature, drug concentration, type of solvents, feed rate ratio of CO2/drug solution, on drug particle formation during SAS process was investigated. Particles with mean particle size ranging between 0.90 and 4.52 μm were obtained by varying process parameters such as precipitation vessel pressure and temperature, drug solution concentration, solvent type, feed rate ratio of CO2/drug solution. In particular, mean particle size and distribution were markedly influenced by drug solution concentration during SAS process. Moreover, the drug did not change its crystal form and the operating parameters might control the 'crystal texture' due to the change in crystallinity and preferred orientation during SAS process, as confirmed by differential scanning calorimetry and powder X-ray diffraction study. In addition, the dissolution rate of drug precipitated using SAS process was highly increased in comparison with unprocessed drug. Therefore, it is concluded that the dissolution rate of drug is significantly increased by micronization of cilostazol, leading to the reduction in particle size and increased specific surface area after SAS process.

AB - The aim of this study was to improve dissolution rate of poorly water-soluble drug, cilostazol, using supercritical antisolvent (SAS) process. The effect of process variables, such as pressure, temperature, drug concentration, type of solvents, feed rate ratio of CO2/drug solution, on drug particle formation during SAS process was investigated. Particles with mean particle size ranging between 0.90 and 4.52 μm were obtained by varying process parameters such as precipitation vessel pressure and temperature, drug solution concentration, solvent type, feed rate ratio of CO2/drug solution. In particular, mean particle size and distribution were markedly influenced by drug solution concentration during SAS process. Moreover, the drug did not change its crystal form and the operating parameters might control the 'crystal texture' due to the change in crystallinity and preferred orientation during SAS process, as confirmed by differential scanning calorimetry and powder X-ray diffraction study. In addition, the dissolution rate of drug precipitated using SAS process was highly increased in comparison with unprocessed drug. Therefore, it is concluded that the dissolution rate of drug is significantly increased by micronization of cilostazol, leading to the reduction in particle size and increased specific surface area after SAS process.

UR - http://www.scopus.com/inward/record.url?scp=34547742600&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547742600&partnerID=8YFLogxK

U2 - 10.1016/j.powtec.2007.02.029

DO - 10.1016/j.powtec.2007.02.029

M3 - Article

AN - SCOPUS:34547742600

VL - 177

SP - 64

EP - 70

JO - Powder Technology

JF - Powder Technology

SN - 0032-5910

IS - 2

ER -